Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: The recent experience at the Rizzoli Institute
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 62, 299-308
- https://doi.org/10.1007/978-1-4615-3518-8_36
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinCancer, 1990
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.Journal of Clinical Oncology, 1988
- The Experience of T10 Protocol in the Pediatric Department of the Gustave Roussy InstitutePublished by Springer Nature ,1988
- Arterial Infusion in the Treatment of OsteosarcomaPublished by Springer Nature ,1988
- Continuous Cisplatin Infusion in Combination with Vincristine and High-Dose Methotrexate for Advanced Osteogenic SarcomaAmerican Journal of Clinical Oncology, 1987
- Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyEuropean Journal of Cancer and Clinical Oncology, 1986
- Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumorCancer, 1985
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982
- A System for the Surgical Staging of Musculoskeletal SarcomaClinical Orthopaedics and Related Research, 1980